Salman Hussain is a panelist during the summit where he is discussing patient-focused drug development in alopecia areata.
For more information on this event, click here.
The socioeconomic impact of rare diseases: An analysis of the evidence in middle-income countries
Worldwide, it is estimated that over 300 million people are living with one or more of the 6,000 to 8,000 identified rare conditions, yet the impact of rare...